These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3212203)

  • 1. [Evaluation of the nature and dynamics of changes in hemostasis in myocardial infarct. I. Antithrombin III and endogenous heparin activities].
    Zapolska-Downar D; Borodin M; Gregorczyk J; Chełstowski K; Sprogis W
    Przegl Lek; 1988; 45(4):387-91. PubMed ID: 3212203
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antithrombin III in the light of modern concepts].
    Dmoszyńska A; Pluta A
    Wiad Lek; 1978 May; 31(10):677-80. PubMed ID: 695577
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Inhibition mechanism of blood coagulation--especially on the function of antithrombin III].
    Sakuragawa N
    Rinsho Byori; 1985 Sep; 33(9):974-81. PubMed ID: 3841167
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antithrombin III and its role in clinical pathology].
    Andreenko GV; Poliantseva LR; Podorol'skaia LV
    Ter Arkh; 1980; 52(2):141-5. PubMed ID: 6445606
    [No Abstract]   [Full Text] [Related]  

  • 5. [The physiological inhibitors of blood coagulation. 1. Antithrombin III (AT III)].
    Kase F; Pospísil J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):337-49. PubMed ID: 6194066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antithrombin III. Physiologic, physiopathologic and laboratory aspects].
    de Sousa JC; Ferreira R; Carriço F; Nunes V; Geraldes MJ; Parreira F; Ribeiro C
    Rev Port Cardiol; 1991 Sep; 10(9):693-9. PubMed ID: 1747261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of natural coagulation inhibitors in hemostasis.
    Brandt JT
    Clin Lab Med; 1984 Jun; 4(2):245-84. PubMed ID: 6094091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the nature and dynamics of hemostatic changes in myocardial infarction. III. Effect of the method of heparin administration on selected parameters of the system of hemostasis].
    Zapolska-Downar D; Borodin M; Gregorczyk J; Chełstowski K; Sprogis W
    Przegl Lek; 1988; 45(6):508-12. PubMed ID: 3252353
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of minidoses of heparin on the blood coagulation and thrombocytic links of hemostasis in myocardial infarct in middle-aged and elderly patients].
    Nechaev DD; Bochko II; Kuz'mina LF; Martynov IV; Khloponina NN
    Ter Arkh; 1987; 59(10):105-8. PubMed ID: 3433205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory activity of plasma antithrombin III and other hypercoagulability indicators in uncomplicated myocardial infarct].
    Psuja P
    Kardiol Pol; 1981; 24(3):207-13. PubMed ID: 7253378
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antithrombin III (AT-III) and low dosage heparin therapy. The prognostic value of AT-III in acute myocardial infarction].
    Mortensen SA; Remvig L; Als OS; Andreasen T
    Ugeskr Laeger; 1983 Apr; 145(14):1056-9. PubMed ID: 6346625
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antithrombin III in patients with acute myocardial infarct in relation to fibrinolytic therapy].
    Soska V; Lupínek Z
    Vnitr Lek; 1987 Mar; 33(3):230-4. PubMed ID: 3660676
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behavior of endogenous blood heparin levels in normal subjects and in myocardial infarct patients].
    Pavero A; Della Pietra S; Cimmino R
    Boll Soc Ital Cardiol; 1970; 15(2):76-81. PubMed ID: 5494528
    [No Abstract]   [Full Text] [Related]  

  • 14. Protease inhibitors of human plasma. Antithrombin-III. "The heparin-antithrombin system".
    Rosenberg RD; Bauer KA; Marcum JA
    J Med; 1985; 16(1-3):351-416. PubMed ID: 3915998
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thrombosis].
    Córdova S; Dorantes-Mesa S; Pizzuto J; Ruiz-Argüelles G; Izaguirre-Avila RA
    Gac Med Mex; 1989; 125(7-8):181-201. PubMed ID: 2534481
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antithrombin III and heparin].
    Zhu KC
    Zhonghua Fu Chan Ke Za Zhi; 1988 May; 23(3):177-9. PubMed ID: 3058418
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antithrombin III deficiency: when substitute, when heparin? Thrombosis ABC, 3: The role of antithrombin III].
    Stiefelhagen P
    MMW Fortschr Med; 1999 Sep; 141(37):41. PubMed ID: 10897973
    [No Abstract]   [Full Text] [Related]  

  • 18. [Regulation of blood coagulation by heparin and related proteins].
    Takahashi K; Niwa M; Yamagishi R; Sakuragawa N
    Rinsho Ketsueki; 1987 Jul; 28(7):1094-101. PubMed ID: 3694818
    [No Abstract]   [Full Text] [Related]  

  • 19. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of antithrombin III in disorders of blood coagulation].
    Król-Grela H; Piastucka B; Skotnicki AB
    Przegl Lek; 1988; 45(6):516-20. PubMed ID: 3075308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.